Date Filed | Type | Description |
08/07/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
08/07/2023 |
8-K
| Investor presentation, Quarterly results |
07/31/2023 |
8-K
| Quarterly results |
07/20/2023 |
8-K
| Quarterly results |
06/29/2023 |
SC 13D/A
| ORBIMED ADVISORS LLC reports a 14.7% stake in Passage BIO, Inc. |
05/26/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
05/11/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
05/11/2023 |
8-K
| Investor presentation, Quarterly results |
04/14/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
04/14/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
04/14/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
04/06/2023 |
8-K
| Entry into a Material Definitive Agreement Interactive Data |
04/03/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
03/10/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
03/06/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
03/06/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
03/06/2023 |
8-K
| Investor presentation, Quarterly results |
02/24/2023 |
8-K
| Investor presentation |
02/14/2023 |
SC 13G/A
| Lynx1 Capital Management LP reports a 6.2% stake in Passage BIO, Inc. |
02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
01/09/2023 |
8-K
| Quarterly results |
12/14/2022 |
8-K
| Quarterly results |
12/02/2022 |
8-K
| Quarterly results |
11/10/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
11/10/2022 |
8-K
| Quarterly results |
10/11/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
09/29/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
08/15/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
08/11/2022 |
8-K
| Quarterly results |
08/04/2022 |
8-K
| Quarterly results |
08/04/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
07/08/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
07/06/2022 |
8-K
| Quarterly results |
06/08/2022 |
8-K
| Quarterly results |
|